| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d986d3b448b2adf84ef6218aa81d0d07 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00 |
| filingDate |
2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a358704cfbcda852451227c6e319d28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61c96c179f6c46f9b36631f1e26370c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5635da07fff2a3ac1b6926cf0897b13d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2baf4c7047e8ab6252275268f61475af |
| publicationDate |
2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017139224-A1 |
| titleOfInvention |
Catheter locking solution and catheter locking therapy |
| abstract |
Various embodiments relate to catheter locking solutions and catheter locking therapies with use of trisodium citrate and ethyl alcohol, and in particular 4.0 to 15.0 weight/volume % trisodium citrate as an anticoagulant component and/or an antibacterial component and 15.0 to 25.0 volume/volume % ethyl alcohol as an antibacterial component. Use of the catheter locking solution and catheter locking therapy can reduce treatment failure during medical procedures that may employ catheters to supply treatment by at least significantly reducing the risks associated with bloodstream infections, catheter system malfunction, emboli formation, patient discomfort, and patient illness. These benefits can be partially due to the synergistic antibacterial effects of the trisodium citrate and ethyl alcohol in solution, generating an effective catheter locking solution with minimal concentrations of ethyl alcohol. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019060697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7138702-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018338194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111278476-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020534106-A |
| priorityDate |
2016-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |